Long Covid in Cancer: A Matched Cohort Study of 1-year Mortality and Long COVID Prevalence Among Patients With Cancer Who Survived an Initial Severe SARS-CoV-2 Infection.
Olivia FankuchenJennifer LauMangala RajanBrandon SwedPeter MartinManuel HidalgoSamuel YamshonLaura PinheiroManish A ShahPublished in: American journal of clinical oncology (2023)
Patients with cancer have higher mortality after hospitalization for acute severe acute respiratory syndrome coronavirus 2 infections. The risk of death was highest in the first 3 months after discharge. About one-third of all patients experienced long COVID.
Keyphrases
- respiratory syndrome coronavirus
- sars cov
- coronavirus disease
- end stage renal disease
- ejection fraction
- risk factors
- chronic kidney disease
- liver failure
- prognostic factors
- papillary thyroid
- cardiovascular disease
- peritoneal dialysis
- drug induced
- respiratory failure
- squamous cell
- patient reported outcomes
- young adults
- lymph node metastasis